Incidence and risk factors for treatment failure with infliximab in psoriasis

J Eur Acad Dermatol Venereol. 2013 Oct;27(10):1323-4. doi: 10.1111/jdv.12077. Epub 2013 Jan 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Incidence
  • Infliximab
  • Kaplan-Meier Estimate
  • Male
  • Psoriasis / drug therapy*
  • Retrospective Studies
  • Risk Factors
  • Treatment Failure

Substances

  • Antibodies, Monoclonal
  • Infliximab